IMSTAR Dx will present an oral communication on November 16th, 2022, at 2 pm in room 241, during the Breast Pathology and Artificial Intelligence session under the title of : Automated evaluation of Ki67 and HER2 markers in breast cancer and Ki67 in ...
IMSTAR Dx est de retour en tant qu'intervenant pour une nouvelle édition de Carrefour Pathologie, tenue à Paris du 16 au 18 Novembre prochains. Notre présentation a pour titre « Evaluation automatisée des marqueurs Ki67 et HER2 dans ...
On October 13th, 2022, IMSTAR will be present at the meeting organized by the Francophone Group of Cytogenetics Hematology (GFCH), affiliated to the French Society of Hematology (SFH) and the French Federation of Human Genetics (FFGH), in person, at the ...
IMSTAR participated in the Computational Pathology Symposium, September 4, 2022. The program of this particularly rich symposium, made it possible to convey a faithful and complete global image of the reality of the field. Speakers from Nordic countri ...
Retour sur notre participation aux 𝟒𝟓𝐞𝐬 𝐀𝐬𝐬𝐢𝐬𝐞𝐬 𝐝𝐞 𝐏𝐚𝐭𝐡𝐨𝐥𝐨𝐠𝐢𝐞 𝐝𝐞 𝐒𝐭𝐫𝐚𝐬𝐛𝐨𝐮𝐫𝐠 les 19 et 20 Mai derniers avec Françoise Soussaline, Mélissande Cossutta et Caroline Egele devant notre poster sous le titre de : 𝐀𝐩𝐩𝐨𝐫𝐭𝐬 𝐝𝐞 𝐥’𝐚𝐧𝐚𝐥𝐲 ...
Venez nous rencontrer aux 45ème Assises de Pathologie, 19-20 Mai 22, Strasbourg Jeudi 19 mai à 15h20 Le Pr Jean-Pierre Bellocq, Président de l'Association Française d'Assurance Qualité (AFAQAP) partagera son expérience des tests d'aptitude inter-la ...
IA-based Solutions Quantitative Digital Pathology
Over 25 years of experience in Intelligent Software solutions, Imstar-Dx is a Spin-off of the CEA’s Nuclear Medicine Department, Life Sciences Division. Imstar-Dx is focused on cancer research and diagnosis since its inception.
© 2021 IMSTAR DX BUSINESS THEME.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
